What is the best muscle relaxant for an elderly woman residing in a skilled‑nursing facility?

Avoid All Traditional Muscle Relaxants in Elderly SNF Residents

The best choice of muscle relaxant for an elderly woman in a skilled nursing facility is to avoid traditional skeletal muscle relaxants entirely, as they are listed on the 2019 AGS Beers Criteria as potentially inappropriate medications for older adults. 1 If true muscle spasm (not just pain) requires treatment, baclofen or a benzodiazepine may be considered as safer alternatives, though both carry significant risks in this population.

Why Traditional Muscle Relaxants Should Be Avoided

The 2019 American Geriatrics Society Beers Criteria explicitly recommends avoiding all traditional muscle relaxants in older adults, including:

• Cyclobenzaprine
• Carisoprodol
• Methocarbamol
• Chlorzoxazone
• Metaxalone
• Orphenadrine

1

Key reasons for avoidance:

• High risk of CNS adverse effects: sedation, confusion, and delirium 1
• Increased fall risk: All skeletal muscle relaxants significantly increase injury risk in older adults (OR 1.32,95% CI 1.16-1.50) 2
• Questionable efficacy: These drugs do not actually relax muscles; their effects are nonspecific and unrelated to muscle relaxation 3
• No superiority over safer alternatives: They have not been proven superior to acetaminophen or NSAIDs for pain relief 4

Specific Agent Risks in the Elderly

Recent comparative data shows important safety differences:

• Cyclobenzaprine: Structurally identical to amitriptyline with similar anticholinergic adverse effects; associated with increased injury risk (OR 1.22) 3, 2
• Carisoprodol: Removed from European market due to abuse concerns; highest injury risk (OR 1.73) 3, 2
• Methocarbamol: Significant injury risk (OR 1.42) despite being marketed as "less sedating" 2
• Baclofen vs. Tizanidine: When muscle relaxants must be used, tizanidine is significantly safer than baclofen in older adults—baclofen carries 3.33 times higher risk of delirium and 1.54 times higher risk of injury 5

When Muscle Relaxation Is Truly Needed

If genuine muscle spasm (not just musculoskeletal pain) requires pharmacologic intervention 3:

First-line consideration:

• Tizanidine: Preferred over baclofen based on 2023 comparative safety data showing lower rates of injury and delirium 5
• Start at very low doses and titrate slowly
• Monitor closely for dizziness and somnolence

Second-line:

• Baclofen: Only if tizanidine fails or is contraindicated 3
• Start low (2.5-5 mg) and increase gradually
• Requires slow tapering if discontinued after prolonged use to avoid withdrawal seizures 3

Alternative for specific situations:

• Benzodiazepines: May be justified for relief of muscle spasm when anxiety and pain coexist, though the high-risk profile in older adults usually outweighs benefits 3

Critical Pitfalls to Avoid

1. Don't prescribe traditional muscle relaxants believing they relieve muscle spasm—their mechanism is nonspecific and unrelated to actual muscle relaxation 3

2. Don't use muscle relaxants for simple musculoskeletal pain—acetaminophen or topical agents are safer first-line options 4

3. Don't continue muscle relaxants long-term—evidence supports only short-term use (4-6 weeks maximum), and long-term use for conditions like low back pain and fibromyalgia shows no benefit 6

4. Don't overlook fall risk in SNF settings—the combination of muscle relaxant-induced sedation and the frail elderly population creates dangerous conditions 1, 2

5. If baclofen is used, never stop abruptly—requires careful tapering to prevent withdrawal toxicity including seizures and delirium 3

The Bottom Line for SNF Practice

In a skilled nursing facility setting where fall risk is already elevated and cognitive impairment is common, the risk-benefit ratio of traditional muscle relaxants is unacceptable. The 2019 Beers Criteria recommendation to avoid these agents carries a strong recommendation with high-quality evidence 1. If pharmacologic muscle relaxation is absolutely necessary after non-pharmacologic approaches fail, tizanidine is the safest option based on the most recent comparative data 5, started at minimal doses with vigilant monitoring for adverse effects.